Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study

Clin Adv Hematol Oncol. 2011 Jun;9(6):492-500.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / secondary
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Capecitabine
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / pathology
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / analogs & derivatives
  • Humans
  • Lapatinib
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / secondary
  • Middle Aged
  • Organoplatinum Compounds / administration & dosage
  • Oxaliplatin
  • Quinazolines / administration & dosage

Substances

  • Organoplatinum Compounds
  • Quinazolines
  • Oxaliplatin
  • Lapatinib
  • Deoxycytidine
  • Capecitabine
  • Fluorouracil